94 related articles for article (PubMed ID: 9277130)
1. Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer?
Maser E
Trends Pharmacol Sci; 1997 Aug; 18(8):270-5. PubMed ID: 9277130
[TBL] [Abstract][Full Text] [Related]
2. 11Beta-hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes.
Maser E
Cancer Res; 1998 Jul; 58(14):2996-3003. PubMed ID: 9679962
[TBL] [Abstract][Full Text] [Related]
3. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung.
Finckh C; Atalla A; Nagel G; Stinner B; Maser E
Chem Biol Interact; 2001 Jan; 130-132(1-3):761-73. PubMed ID: 11306092
[TBL] [Abstract][Full Text] [Related]
4. Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung.
Atalla A; Maser E
Toxicology; 1999 Nov; 139(1-2):155-66. PubMed ID: 10614696
[TBL] [Abstract][Full Text] [Related]
5. The identification of 11 beta-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Maser E; Richter E; Friebertshäuser J
Eur J Biochem; 1996 Jun; 238(2):484-9. PubMed ID: 8681962
[TBL] [Abstract][Full Text] [Related]
6. Interindividual variability in the expression and NNK carbonyl reductase activity of 11beta-hydroxysteroid dehydrogenase 1 in human lung.
Soldan M; Nagel G; Losekam M; Ernst M; Maser E
Cancer Lett; 1999 Oct; 145(1-2):49-56. PubMed ID: 10530769
[TBL] [Abstract][Full Text] [Related]
7. Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen.
Maser E; Friebertshäuser J; Völker B
Chem Biol Interact; 2003 Feb; 143-144():435-48. PubMed ID: 12604230
[TBL] [Abstract][Full Text] [Related]
8. Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver.
Breyer-Pfaff U; Martin HJ; Ernst M; Maser E
Drug Metab Dispos; 2004 Sep; 32(9):915-22. PubMed ID: 15319331
[TBL] [Abstract][Full Text] [Related]
9. Carbonyl reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytosolic enzymes in human liver and lung.
Maser E; Stinner B; Atalla A
Cancer Lett; 2000 Feb; 148(2):135-44. PubMed ID: 10695989
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man.
Richter E; Engl J; Friesenegger S; Tricker AR
Chem Res Toxicol; 2009 Jun; 22(6):1008-17. PubMed ID: 19408892
[TBL] [Abstract][Full Text] [Related]
11. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer
Biomarkers; 2000; 5(1):33-45. PubMed ID: 23885904
[TBL] [Abstract][Full Text] [Related]
12. The Role of Placental Carbonyl Reducing Enzymes in Biotransformation of Bupropion and 4-methylnitrosamino-1-(3-pyridyl)-1-butanone.
Fokina VM; Patrikeeva SL; Oncken C; Hankins GDV; Ahmed MS; Nanovskaya T
Drug Metab Lett; 2017 Nov; 11(1):29-34. PubMed ID: 28595558
[TBL] [Abstract][Full Text] [Related]
13. Characterization of enzymes participating in carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human placenta.
Atalla A; Maser E
Chem Biol Interact; 2001 Jan; 130-132(1-3):737-48. PubMed ID: 11306090
[TBL] [Abstract][Full Text] [Related]
14. The effect of a 2-h exposure to cigarette smoke on the metabolic activation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice.
Brown BG; Richter E; Tricker AR; Ayres PH; Doolittle DJ
Chem Biol Interact; 2001 Nov; 138(2):125-35. PubMed ID: 11672696
[TBL] [Abstract][Full Text] [Related]
15. Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via alpha-hydroxylation and carbonyl reduction pathways.
Prokopczyk B; Trushin N; Leszczynska J; Waggoner SE; El-Bayoumy K
Carcinogenesis; 2001 Jan; 22(1):107-14. PubMed ID: 11159748
[TBL] [Abstract][Full Text] [Related]
16. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
17. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.
Jalas JR; Ding X; Murphy SE
Drug Metab Dispos; 2003 Oct; 31(10):1199-202. PubMed ID: 12975327
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats.
Guo Z; Smith TJ; Thomas PE; Yang CS
Arch Biochem Biophys; 1992 Oct; 298(1):279-86. PubMed ID: 1524438
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human placental microsomes.
Collazo NR; Sultatos LG
Biochem Pharmacol; 1995 Nov; 50(11):1933-41. PubMed ID: 8615875
[TBL] [Abstract][Full Text] [Related]
20. The effect of tobacco smoke, nicotine, and cotinine on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
Brown B; Avalos J; Lee C; Doolittle D
Mutat Res; 2001 Jul; 494(1-2):21-9. PubMed ID: 11423342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]